The leukopoietic cytokine granulocyte colony-stimulating factor increases blood flow to rat bone marrow

The current knowledge concerning the blood supply to hematopoietic bone marrow during increased marrow metabolism is scanty. We have previously shown that an accelerated erythropoiesis in the awake rat is accompanied by a rapid increase in perfusion of the tibial marrow and its bony encasement. We h...

Full description

Saved in:
Bibliographic Details
Published inExperimental hematology Vol. 21; no. 2; p. 231
Main Authors Iversen, P O, Nicolaysen, G, Benestad, H B
Format Journal Article
LanguageEnglish
Published Netherlands 01.02.1993
Subjects
Animals
Bone Marrow - blood supply
Bone Marrow - metabolism
Granulocyte Colony-Stimulating Factor - administration & dosage
Granulocyte Colony-Stimulating Factor - pharmacology
Injections, Subcutaneous
Intestine, Small - blood supply
Kidney - blood supply
Liver - blood supply
Muscles - blood supply
Rats
Recombinant Proteins - pharmacology
Regional Blood Flow - drug effects
Skin - blood supply
Spleen - blood supply
Tibia
Time Factors
Online AccessGet more information

Cover

More Information
Summary:The current knowledge concerning the blood supply to hematopoietic bone marrow during increased marrow metabolism is scanty. We have previously shown that an accelerated erythropoiesis in the awake rat is accompanied by a rapid increase in perfusion of the tibial marrow and its bony encasement. We have now measured blood flow to tibial marrow and bone in rats with stimulated granulopoiesis, caused by injection of recombinant human granulocyte colony-stimulating factor (rhG-CSF). In awake, adult rats, blood flow was measured with the microsphere method before and at intervals during a 48-hour period after subcutaneous (s.c.) injection of rhG-CSF (10 micrograms/kg). Administration of rhG-CSF caused a marked leukocytosis, mostly due to an increase in blood granulocytes, amounting to 4 times the control value at 8 hours. Concomitantly, the perfusion of tibial marrow rose to about 200% of control by 8 hours before it declined toward baseline. Denervation of the marrow had no effect on this hyperemic response. The perfusion of tibial bone was apparently unaffected by rhG-CSF injection. We conclude that rhG-CSF injection increases blood flow to hematopoietic marrow, but not to bone. This may have important implications for marrow transplantation and drug therapy for patients with marrow failure.
ISSN:0301-472X